Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.
Saved in:
| Title: | Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance. |
|---|---|
| Authors: | Shorr, Andrew F.1 (AUTHOR), Jones, Mark E.2 (AUTHOR), Friedmann, Silke2 (AUTHOR), Ionescu, Daniel2 (AUTHOR), Saulay, Mikael2 (AUTHOR), Smart, Jennifer I.2 (AUTHOR), Engelhardt, Marc2 (AUTHOR) Marc.engelhardt@basilea.com |
| Source: | PLoS ONE. 6/24/2025, Vol. 20 Issue 6, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0326758 |
